Tianhui Chuangtou is an investment firm that provides asset management and investment consulting service.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Aug 31, 2022
Baiying Bio
|
Series B | ¥500M | Biotechnology | — |
Jun 4, 2021
Simcere Pharma
|
Series B | ¥600M | Biotechnology | — |
Mar 12, 2021
Novamab
|
Series A | ¥100M | Biotechnology | Yes |
Jan 1, 2015
Souqiantu.com
|
Angel | ¥3M | Human Resources | — |
Tianhui Chuangtou has had 1 exits. Tianhui Chuangtou most notable exits include Simcere Pharma
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 27, 2020 | Simcere Pharma | IPO | Biotechnology | Detail |